Functional profiling of LDLR variants: Important evidence for variant classification: Functional profiling of LDLR variants

J Clin Lipidol. 2022 Jul-Aug;16(4):516-524. doi: 10.1016/j.jacl.2022.04.005. Epub 2022 Apr 30.

Abstract

Background: Familial Hypercholesterolemia (FH) is a semidominant disorder of the lipid metabolism associated with premature atherosclerosis and coronary heart disease. So far, about 3,000 unique LDLR variants have been described, most of which lack functional evidence proving their effect on LDLR function, despite the important role that functional studies play in variant classification.

Objective: In this work, we aimed to functionally characterize 13 rare missense variants, identified worldwide and in Portugal, in clinical FH patients.

Methods: LDLR-deficient CHO-ldlA7 cells were transfected with plasmids carrying different LDLR variants generated by site-directed mutagenesis. LDLR activity and expression were assessed by FACS.

Results: 11/13 variants affect LDLR function (p.Cys109Phe; p.Cys143Arg; p.Glu267Lys; p.Cys352Ser; p.Ile451Thr; p.His485Gln; p.Asp492Asn; p.Val500Ala; p.Gly529Arg; p.Phe614Ile; p.Glu626Lys) and 2/13 are inconclusive (p.Arg81Cys; p.Gly98Arg;).

Conclusion: Of the 13 variants studied, 8 were classified as VUS by ACMG criteria, but for 7 of these 8, our functional studies were able to reassign them as Likely pathogenic or Pathogenic. For an accurate diagnosis, an effort must be made to improve functional characterization of putative disease-causing variants.

Keywords: Definitive diagnosis; Familial Hypercholesterolemia; Functional studies; LDL receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Humans
  • Hyperlipoproteinemia Type II* / diagnosis
  • Mutation
  • Mutation, Missense
  • Phenotype
  • Receptors, LDL* / genetics
  • Receptors, LDL* / metabolism

Substances

  • Receptors, LDL